Block, Siteadmin, SkipCaptcha, Upload, Automoderated users, delete, edit, move, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, protect, rollback, Administrators, template
293,584
edits
Changes
Jump to navigation
Jump to search
Line 8:
Line 8: + + + +
no edit summary
Some suspect that overuse of remdesivir may result in viral resistance to the drug, which is a strong reason to prefer hydroxychloroquine over remdesivir.
Some suspect that overuse of remdesivir may result in viral resistance to the drug, which is a strong reason to prefer hydroxychloroquine over remdesivir.
The Remdesivir data from the Medicare Tracking System reveals of the 7,960 beneficiaries prescribed Remdesivir for Covid-19, 2,058 died. That is 25.9%.
46% of people died within 14 days of the Remdesivir Treatment. The Remdesivir Treatment was established in U.S. Hospitals at the direction of Dr. [[Anthony Fauci]]. Serious adverse events were reported in 131 of the 532 patients who received Remdesivir. That is 24.6%.<ref>https://theconservativetreehouse.com/blog/2021/10/01/attorney-thomas-renz-releases-medicare-and-pfizer-whistleblower-data-vaccine-related-injuries-and-deaths-far-more-widespread-than-reported/</ref>
==References==
==References==